Original Query: ALL
Previous Study | Return to List | Next Study

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00510471
Recruitment Status : Terminated
First Posted : August 2, 2007
Last Update Posted : March 18, 2008
Information provided by:
Genitope Corporation

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : No date given